NASDAQ: EXOZ
Exozymes Inc Stock Ownership - Who owns Exozymes?

Insider buying vs selling

Have Exozymes Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael HeltzenCEO2026-08-264$7.58
$30.32Buy
Michael HeltzenCEO2026-08-26251$7.35
$1.84kBuy
Michael HeltzenCEO2026-08-26250$7.60
$1.90kBuy
Michael HeltzenCEO2026-08-25250$7.52
$1.88kBuy
Michael HeltzenCEO2026-08-25100$7.50
$750.00Buy
Michael HeltzenCEO2026-08-198,841$6.40
$56.58kBuy
Tyler Paz KormanChief Scientific Officer2026-04-09750$10.53
$7.89kSell
Tyler Paz KormanChief Scientific Officer2026-04-08750$10.04
$7.53kSell
Damien Alan PerrimanChief Commercial Officer2026-04-018,887$8.44
$75.01kSell
Tyler Paz KormanChief Scientific Officer2026-04-015,332$8.44
$45.00kBuy

1 of 2

EXOZ insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EXOZ insiders and whales buy or sell their stock.

EXOZ Shareholders

What type of owners hold Exozymes Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Anthony Digiandomenico41.03%3,808,476$23.92MInsider
Mdb Capital Holdings LLC41.03%3,808,476$23.92MInsider
Christopher A. Marlett41.03%3,808,476$23.92MInsider
Tyler Paz Korman8.22%762,837$4.79MInsider
Paul Hideo Opgenorth6.95%645,149$4.05MInsider
James Ulrich Bowie6.23%577,910$3.63MInsider
Mohammad Hayat1.68%155,818$978.54kInsider
Edgardo Javier Rayo0.84%77,909$489.27kInsider
Damien Alan Perriman0.31%28,499$178.97kInsider
Michael Heltzen0.16%14,453$90.76kInsider

1 of 4

EXOZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EXOZ0.00%100.00%Net BuyingNet Buying
RNTX0.05%41.65%Net Buying
FRMM0.02%99.98%Net SellingNet Selling
ALGS0.01%99.99%
SER0.00%100.00%Net BuyingNet Buying

Exozymes Stock Ownership FAQ

Who owns Exozymes?

Exozymes (NASDAQ: EXOZ) is owned by 0.00% institutional shareholders, 147.58% Exozymes insiders, and 0.00% retail investors. Anthony Digiandomenico is the largest individual Exozymes shareholder, owning 3.81M shares representing 41.03% of the company. Anthony Digiandomenico's Exozymes shares are currently valued at $25.04M.

If you're new to stock investing, here's how to buy Exozymes stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.